(Q44577987)

4 December 2017

title

Purification of recombinant plasminogen activator inhibitor-1 in the active conformation by refolding from inclusion bodies (English)

1 reference

4 December 2017

1 reference

Hak-Joo Lee

1

1 reference

4 December 2017

Hana Im

series ordinal

2

1 reference

4 December 2017

language of work or name

1 reference

1 September 2003

1 reference

Protein Expression and Purification

4 December 2017

published in

1 reference

4 December 2017

volume

31

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

99-107

1 reference

Purification and characterization of natural and recombinant human plasminogen activator inhibitor-1 (PAI-1)

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

The urokinase receptor and regulation of cell surface plasminogen activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Principles that govern the folding of protein chains

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

The structure and function of the hemagglutinin membrane glycoprotein of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

What do dysfunctional serpins tell us about molecular mobility and disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Influenza hemagglutinin is spring-loaded by a metastable native conformation

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Metastability in the inhibitory mechanism of human alpha1-antitrypsin

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Regulation of protein function by native metastability

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Structural basis for serpin inhibitor activity

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Divining the serpin inhibition mechanism: a suicide substrate 'springe'?

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Structure of a serpin-protease complex shows inhibition by deformation

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Structural basis of latency in plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Latent alpha1-antichymotrypsin. A molecular explanation for the inactivation of alpha1-antichymotrypsin in chronic bronchitis and emphysema.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Plasminogen activator inhibitor from human endothelial cells. Purification and partial characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Proteinase specificity and functional diversity in point mutants of plasminogen activator inhibitor 1

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Kinetically controlled folding of the serpin plasminogen activator inhibitor 1

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Refolding of alpha 1-antitrypsin expressed as inclusion bodies in Escherichia coli: characterization of aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Role of Lys335 in the metastability and function of inhibitory serpins

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Multiphasic zone electrophoresis, IV. Design and analysis of discontinuous buffer systems with a digital computer

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Purification and characterization of active and stable recombinant plasminogen-activator inhibitor accumulated at high levels in Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Polymerization of plasminogen activator inhibitor-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900160-8

7 January 2021

10.1016/S1046-5928(03)00160-8

Identifiers

DOI

1 reference

4 December 2017

1 reference